Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Cresco Labs Inc banner
C

Cresco Labs Inc
CNSX:CL

Watchlist Manager
Cresco Labs Inc
CNSX:CL
Watchlist
Price: 1.35 CAD 1.5% Market Closed
Market Cap: CA$709.6m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
-27%
5Y
+6%
10Y
-
Liabilities
+
3Y
-12%
5Y
+43%
10Y
-
Equity
+
3Y
-46%
5Y
-30%
10Y
-

Balance Sheet Decomposition
Cresco Labs Inc

Balance Sheet
Cresco Labs Inc

Rotate your device to view
Balance Sheet
Currency: USD
Jan-2002 Jan-2003 Jan-2004 Jan-2005 Jan-2006 Jan-2007 Jan-2008 Jan-2009 Jan-2010 Jan-2011 Jan-2012 Jan-2013 Jan-2014 Jan-2015 Jan-2016 Jan-2017 Jan-2018 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
131
49
136
224
119
103
138
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash Equivalents
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
131
49
136
224
119
103
138
Short-Term Investments
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11
17
32
45
57
52
52
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
16
30
43
56
51
52
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
1
2
1
0
1
1
Inventory
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25
81
67
137
135
108
83
Other Current Assets
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25
12
14
17
15
14
21
Total Current Assets
0
0
1
1
0
0
1
0
0
0
0
0
0
0
0
0
0
193
159
249
422
326
278
294
PP&E Net
0
0
0
0
1
1
1
4
2
0
0
0
0
0
0
0
0
40
203
301
457
508
486
456
PP&E Gross
0
0
0
0
1
1
1
4
2
0
0
0
0
0
0
0
0
0
203
301
457
508
486
456
Accumulated Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
24
50
78
121
162
Intangible Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25
94
196
438
408
297
294
Goodwill
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51
138
451
447
331
280
283
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
19
21
1
1
1
2
Long-Term Investments
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
4
6
1
1
1
Other Long-Term Assets
0
0
0
1
4
4
6
0
0
0
0
0
0
0
0
0
0
1
3
11
11
9
16
26
Other Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51
138
451
447
331
280
283
Total Assets
0
N/A
0
+33%
1
+125%
3
+211%
5
+79%
5
N/A
7
+42%
4
-39%
3
-42%
0
-84%
0
-50%
0
N/A
0
N/A
0
-43%
0
+5%
0
-37%
0
-98%
318
+18 712 312%
617
+94%
1 233
+100%
1 780
+44%
1 584
-11%
1 358
-14%
1 355
0%
Liabilities
Accounts Payable
0
0
0
0
0
0
1
1
1
1
0
0
0
0
0
0
0
8
32
23
32
28
28
14
Accrued Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30
130
95
65
77
64
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26
20
19
10
9
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
18
21
26
4
5
Other Current Liabilities
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
0
18
76
55
120
143
82
3
Total Current Liabilities
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
25
150
253
288
281
200
94
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
83
330
584
625
520
481
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
23
41
86
75
40
39
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
162
136
102
42
39
78
87
Other Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
37
33
25
15
170
353
Total Liabilities
1
N/A
0
-20%
0
-50%
0
N/A
0
+50%
1
+67%
1
N/A
1
+80%
1
+11%
1
+10%
1
-36%
1
+43%
1
+10%
1
-17%
1
+2%
1
+5%
1
+1%
197
+19 799%
429
+118%
759
+77%
1 025
+35%
957
-7%
853
-11%
881
+3%
Equity
Common Stock
3
3
5
7
10
11
13
11
13
14
14
14
12
10
10
10
10
162
276
802
1 598
1 705
1 689
1 707
Retained Earnings
3
3
4
5
7
8
10
10
14
18
14
14
16
13
14
14
14
53
115
328
842
1 076
1 266
1 352
Additional Paid In Capital
0
0
0
1
2
2
3
3
3
3
0
0
3
3
3
3
3
12
26
0
0
0
83
123
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
1
2
Total Equity
0
N/A
0
N/A
1
N/A
3
+257%
5
+88%
5
-4%
7
+47%
3
-48%
2
-56%
1
N/A
1
+29%
1
-60%
1
-13%
1
+11%
1
-2%
1
-12%
1
-9%
121
N/A
187
+55%
473
+153%
756
+60%
627
-17%
506
-19%
475
-6%
Total Liabilities & Equity
0
N/A
0
+33%
1
+125%
3
+211%
5
+79%
5
N/A
7
+42%
4
-39%
3
-42%
0
-84%
0
-50%
0
N/A
0
N/A
0
-43%
0
+5%
0
-37%
0
-98%
318
+18 712 312%
617
+94%
1 233
+100%
1 780
+44%
1 584
-11%
1 358
-14%
1 355
0%
Shares Outstanding
Common Shares Outstanding
6
7
11
15
18
18
21
21
24
24
28
28
28
28
28
28
28
254
274
350
401
408
437
441

See Also

Summary
CL intrinsic value, competitors valuation, and company profile.
DCF Valuation
CL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CL stock valuation using valuation multiples.
Wall Street Estimates
CL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 317,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.